Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IKBKB | O14920 | 18/20 | 0.61 |
| ▸ | CHUK | O15111 | 18/20 | 0.61 |
| ▸ | MBTD1 | Q05BQ5 | 1/20 | 0.57 |
| ▸ | L3MBTL3 | Q96JM7 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | IKBKG | Q9Y6K9 | 8/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | RECQL | P46063 | 1/20 | 0.54 |
| ▸ | BLM | P54132 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | MTOR | P42345 | 1/20 | 0.51 |
| ▸ | SMG1 | Q96Q15 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8311423 | 0.93 | IKBKB (0.67) | IKBKBCHUKMTORSMG1 | |
| SCHEMBL8311421 | 0.92 | IKBKB (0.66) | IKBKBCHUKMTORSMG1 | |
| SCHEMBL8312614 | 0.92 | IKBKB (0.66) | IKBKBCHUKMTORSMG1 | |
| SCHEMBL8308663 | 0.91 | MBTD1 (0.61) | IKBKBCHUKMBTD1L3MBTL3L3MBTL1 | |
| SCHEMBL8313896 | 0.91 | IKBKB (0.63) | IKBKBCHUKMTORSMG1 | |
| SCHEMBL14063888 | 0.91 | IKBKB (0.63) | IKBKBCHUKKMT2A | |
| SCHEMBL8308545 | 0.91 | IKBKB (0.69) | IKBKBCHUKMTORSMG1 | |
| SCHEMBL8308969 | 0.89 | MBTD1 (0.57) | IKBKBCHUKMBTD1L3MBTL3L3MBTL1 | |
| SCHEMBL8308666 | 0.88 | IKBKB (0.65) | IKBKBCHUK | |
| SCHEMBL8311631 | 0.87 | IKBKB (0.59) | IKBKBCHUKMTORSMG1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7429599-B2 | Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK | SIGNAL PHARMACEUTICALS, LLC (US) | 2008-09-30 | — | — | US | disclosed |
| US-7429599-B2 | Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK | SIGNAL PHARMACEUTICALS, LLC (US) | 2008-09-30 | — | — | US | disclosed |
| WO-2004084901-A1 | METHODS FOR TREATING OR PREVENTING AN INFLAMMATORY OR METABOLIC CONDITION BY INHIBITING JNK | SIGNAL PHARMACEUTICALS, LLC (US) | 2004-10-07 | — | — | WO | disclosed |